TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs61786357
log Bayes Factor = 5.38959
Chromosome 1   position 97,775,113  (GRCh37) Explore rs61786357 on Ensembl!
Variant rs61786357 is part of Cluster X0092

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C78 Secondary malignant neoplasm of respiratory and digestive organs
1.000 0.000 0.000
C79 Secondary malignant neoplasm of other sites
1.000 0.000 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
1.000 0.000 0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.996 0.004 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.978 0.022 0.000
C78.2 Secondary malignant neoplasm of pleura
0.974 0.026 0.000
C78.0 Secondary malignant neoplasm of lung
0.969 0.031 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.940 0.060 0.000
C79.2 Secondary malignant neoplasm of skin
0.935 0.065 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.931 0.069 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.927 0.073 0.000
C80 Malignant neoplasm without specification of site
0.917 0.083 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.894 0.106 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.892 0.108 0.000
C79.6 Secondary malignant neoplasm of ovary
0.885 0.115 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.879 0.121 0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.820 0.180 0.000
C78.4 Secondary malignant neoplasm of small intestine
0.747 0.253 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.718 0.282 0.000
C78.7 Secondary malignant neoplasm of liver
0.702 0.298 0.000
C32 Malignant neoplasm of larynx
0.677 0.323 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.677 0.323 0.000
Chapter II Neoplasms
0.668 0.332 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.667 0.332 0.000
Z51.1 Chemotherapy session for neoplasm
0.665 0.335 0.000
C32.9 Larynx, unspecified
0.650 0.350 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.636 0.364 0.000
C32.1 Supraglottis
0.635 0.365 0.000
C51-C58 Malignant neoplasms of female genital organs
0.635 0.365 0.000
C34 Malignant neoplasm of bronchus and lung
0.633 0.367 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.630 0.369 0.000
C56 Malignant neoplasm of ovary
0.628 0.372 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.626 0.374 0.000
C32.0 Glottis
0.605 0.395 0.000
C34.9 Bronchus or lung, unspecified
0.601 0.399 0.000
C92 Myeloid leukaemia
0.593 0.407 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.589 0.411 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.577 0.423 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.576 0.424 0.000
D00-D09 In situ neoplasms
0.573 0.427 0.000
C92.0 Acute myeloid leukaemia
0.561 0.439 0.000
C64-C68 Malignant neoplasms of urinary tract
0.554 0.446 0.000
C88 Malignant immunoproliferative diseases
0.553 0.447 0.000
C76.0 Head, face and neck
0.546 0.454 0.000
C33 Malignant neoplasm of trachea
0.545 0.455 0.000
C77.8 Lymph nodes of multiple regions
0.539 0.461 0.000
D03 Melanoma in situ
0.537 0.463 0.000
D09 Carcinoma in situ of other and unspecified sites
0.526 0.474 0.000
C76.2 Abdomen
0.525 0.475 0.000
D03.5 Melanoma in situ of trunk
0.522 0.478 0.000
C77.0 Lymph nodes of head, face and neck
0.520 0.480 0.000
C76.8 Overlapping lesion of other and ill-defined sites
0.515 0.485 0.000
C76.7 Other ill-defined sites
0.515 0.485 0.000
C76.5 Lower limb
0.515 0.485 0.000
C76.4 Upper limb
0.515 0.485 0.000
C55 Malignant neoplasm of uterus, part unspecified
0.513 0.487 0.000
C34.3 Lower lobe, bronchus or lung
0.511 0.489 0.000
C80.9 Malignant neoplasm, unspecified
0.508 0.491 0.000
C90.0 Multiple myeloma
0.504 0.496 0.000
C76.1 Thorax
0.496 0.504 0.000
C77.3 Axillary and upper limb lymph nodes
0.494 0.506 0.000
C76.3 Pelvis
0.490 0.510 0.000
D02 Carcinoma in situ of middle ear and respiratory system
0.487 0.513 0.000
C32.8 Overlapping lesion of larynx
0.485 0.514 0.000
C32.3 Laryngeal cartilage
0.485 0.514 0.000
C32.2 Subglottis
0.485 0.514 0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.485 0.515 0.000
C31 Malignant neoplasm of accessory sinuses
0.485 0.515 0.000
C30 Malignant neoplasm of nasal cavity and middle ear
0.484 0.516 0.000
D09.0 Bladder
0.479 0.521 0.000
D03.6 Melanoma in situ of upper limb, including shoulder
0.477 0.523 0.000
C86 Other specified types of T/NK-cell lymphoma
0.474 0.526 0.000
C95 Leukaemia of unspecified cell type
0.473 0.527 0.000
C67 Malignant neoplasm of bladder
0.472 0.528 0.000
C34.2 Middle lobe, bronchus or lung
0.466 0.534 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.465 0.535 0.000
C34.8 Overlapping lesion of bronchus and lung
0.463 0.537 0.000
C93 Monocytic leukaemia
0.462 0.538 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.459 0.541 0.000
C90.1 Plasma cell leukaemia
0.458 0.542 0.000
C58 Malignant neoplasm of placenta
0.455 0.545 0.000
C51 Malignant neoplasm of vulva
0.454 0.546 0.000
C92.1 Chronic myeloid leukaemia
0.454 0.546 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.449 0.551 0.000
C94 Other leukaemias of specified cell type
0.449 0.551 0.000
C90.3 Solitary plasmacytoma
0.446 0.554 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.444 0.556 0.000
C67.2 Lateral wall of bladder
0.442 0.558 0.000
C92.4 Acute promyelocytic leukaemia
0.436 0.564 0.000
C90.2 Plasmacytoma, extramedullary
0.435 0.565 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.433 0.567 0.000
C38 Malignant neoplasm of heart, mediastinum and pleura
0.431 0.569 0.000
D02.0 Larynx
0.425 0.575 0.000
C92.9 Myeloid leukaemia, unspecified
0.425 0.575 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.425 0.575 0.000
C92.7 Other myeloid leukaemia
0.425 0.575 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.425 0.575 0.000
C92.5 Acute myelomonocytic leukaemia
0.425 0.575 0.000
C92.3 Myeloid sarcoma
0.425 0.575 0.000
C92.2 Subacute myeloid leukaemia
0.425 0.575 0.000
C64 Malignant neoplasm of kidney, except renal pelvis
0.425 0.575 0.000
D06 Carcinoma in situ of cervix uteri
0.418 0.582 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.417 0.583 0.000
C60-C63 Malignant neoplasms of male genital organs
0.417 0.583 0.000
C37 Malignant neoplasm of thymus
0.417 0.583 0.000
C34.0 Main bronchus
0.417 0.583 0.000
C53 Malignant neoplasm of cervix uteri
0.416 0.584 0.000
D09.9 Carcinoma in situ, unspecified
0.413 0.587 0.000
D01 Carcinoma in situ of other and unspecified digestive organs
0.412 0.588 0.000
D03.0 Melanoma in situ of lip
0.412 0.588 0.000
D03.4 Melanoma in situ of scalp and neck
0.410 0.590 0.000
C68 Malignant neoplasm of other and unspecified urinary organs
0.405 0.595 0.000
C57 Malignant neoplasm of other and unspecified female genital organs
0.404 0.596 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.403 0.597 0.000
Y43.3 Other antineoplastic drugs
0.400 0.600 0.000
C34.1 Upper lobe, bronchus or lung
0.399 0.601 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.397 0.603 0.000
C88.7 Other malignant immunoproliferative diseases
0.397 0.603 0.000
C88.3 Immunoproliferative small intestinal disease
0.397 0.603 0.000
C88.2 Gamma heavy chain disease
0.397 0.603 0.000
C88.1 Alpha heavy chain disease
0.397 0.603 0.000
C50-C50 Malignant neoplasm of breast
0.391 0.609 0.000
C65 Malignant neoplasm of renal pelvis
0.390 0.610 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.390 0.610 0.000
C67.8 Overlapping lesion of bladder
0.387 0.613 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.386 0.614 0.000
D03.9 Melanoma in situ, unspecified
0.385 0.615 0.000
D03.8 Melanoma in situ of other sites
0.385 0.615 0.000
C67.4 Posterior wall of bladder
0.385 0.615 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.384 0.615 0.000
D09.1 Other and unspecified urinary organs
0.384 0.616 0.000
C62 Malignant neoplasm of testis
0.381 0.619 0.000
C77.4 Inguinal and lower limb lymph nodes
0.378 0.622 0.000
D09.7 Carcinoma in situ of other specified sites
0.377 0.623 0.000
D09.3 Thyroid and other endocrine glands
0.377 0.623 0.000
D09.2 Eye
0.377 0.623 0.000
C81 Hodgkin's disease
0.376 0.624 0.000
D03.1 Melanoma in situ of eyelid, including canthus
0.374 0.625 0.000
C52 Malignant neoplasm of vagina
0.374 0.626 0.000
D03.2 Melanoma in situ of ear and external auricular canal
0.367 0.633 0.000
C66 Malignant neoplasm of ureter
0.367 0.633 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.364 0.636 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.357 0.643 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.357 0.643 0.000
C67.3 Anterior wall of bladder
0.356 0.644 0.000
C67.1 Dome of bladder
0.353 0.647 0.000
D02.4 Respiratory system, unspecified
0.349 0.651 0.000
D02.3 Other parts of respiratory system
0.349 0.651 0.000
D02.2 Bronchus and lung
0.349 0.651 0.000
D02.1 Trachea
0.349 0.651 0.000
C95.0 Acute leukaemia of unspecified cell type
0.349 0.651 0.000
C31.9 Accessory sinus, unspecified
0.348 0.652 0.000
C31.8 Overlapping lesion of accessory sinuses
0.348 0.652 0.000
C31.3 Sphenoidal sinus
0.348 0.652 0.000
C31.2 Frontal sinus
0.348 0.652 0.000
C31.1 Ethmoidal sinus
0.348 0.652 0.000
C31.0 Maxillary sinus
0.348 0.652 0.000
C39.9 Ill-defined sites within the respiratory system
0.348 0.652 0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs
0.348 0.652 0.000
C39.0 Upper respiratory tract, part unspecified
0.348 0.652 0.000
C30.1 Middle ear
0.347 0.653 0.000
C62.9 Testis, unspecified
0.346 0.654 0.000
C30.0 Nasal cavity
0.345 0.654 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.345 0.655 0.000
C93.1 Chronic monocytic leukaemia
0.345 0.655 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.344 0.656 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.340 0.660 0.000
C86.4 Blastic NK-cell lymphoma
0.340 0.660 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.340 0.660 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.340 0.660 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.340 0.660 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.340 0.660 0.000
C95.7 Other leukaemia of unspecified cell type
0.339 0.661 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.339 0.661 0.000
C67.7 Urachus
0.338 0.661 0.000
C95.9 Leukaemia, unspecified
0.337 0.663 0.000
C51.9 Vulva, unspecified
0.336 0.664 0.000
D06.1 Exocervix
0.334 0.666 0.000
Y43 Primarily systemic agents
0.333 0.667 0.000
C93.9 Monocytic leukaemia, unspecified
0.332 0.668 0.000
C93.7 Other monocytic leukaemia
0.332 0.668 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.332 0.668 0.000
C93.2 Subacute monocytic leukaemia
0.332 0.668 0.000
C93.0 Acute monocytic leukaemia
0.332 0.668 0.000
C91 Lymphoid leukaemia
0.329 0.671 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.328 0.672 0.000
C51.8 Overlapping lesion of vulva
0.326 0.674 0.000
C51.2 Clitoris
0.326 0.674 0.000
C51.1 Labium minus
0.326 0.674 0.000
C94.7 Other specified leukaemias
0.322 0.678 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.322 0.678 0.000
C94.5 Acute myelofibrosis
0.322 0.678 0.000
C94.4 Acute panmyelosis
0.322 0.678 0.000
C94.3 Mast cell leukaemia
0.322 0.678 0.000
C94.2 Acute megakaryoblastic leukaemia
0.322 0.678 0.000
C94.1 Chronic erythraemia
0.322 0.678 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.322 0.678 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.322 0.678 0.000
C96.8 Histiocytic sarcoma
0.322 0.678 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.322 0.678 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.322 0.678 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.322 0.678 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.322 0.678 0.000
C96.3 True histiocytic lymphoma
0.322 0.678 0.000
C96.2 Malignant mast cell tumour
0.322 0.678 0.000
C96.1 Malignant histiocytosis
0.322 0.678 0.000
C96.0 Letterer-Siwe disease
0.322 0.678 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.322 0.678 0.000
D07.5 Prostate
0.320 0.680 0.000
C77.1 Intrathoracic lymph nodes
0.318 0.682 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.314 0.686 0.001
C82.3 Follicular lymphoma grade IIIa
0.314 0.686 0.000
C51.0 Labium majus
0.313 0.686 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.312 0.688 0.000
C67.0 Trigone of bladder
0.312 0.688 0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)
0.310 0.689 0.000
C82.0 Small cleaved cell, follicular
0.311 0.689 0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura
0.309 0.691 0.000
C38.3 Mediastinum, part unspecified
0.309 0.691 0.000
C38.2 Posterior mediastinum
0.309 0.691 0.000
C38.1 Anterior mediastinum
0.309 0.691 0.000
C38.0 Heart
0.309 0.691 0.000
C53.9 Cervix uteri, unspecified
0.308 0.692 0.000
D01.3 Anus and anal canal
0.305 0.695 0.000
C54 Malignant neoplasm of corpus uteri
0.305 0.695 0.000
D01.2 Rectum
0.301 0.699 0.000
D06.7 Other parts of cervix
0.300 0.700 0.000
C68.0 Urethra
0.300 0.700 0.000
C82.6 Cutaneous follicle centre lymphoma
0.299 0.701 0.000
C82.5 Diffuse follicle centre lymphoma
0.299 0.701 0.000
C82.4 Follicular lymphoma grade IIIb
0.299 0.701 0.000
C63 Malignant neoplasm of other and unspecified male genital organs
0.299 0.701 0.000
C62.1 Descended testis
0.299 0.701 0.000
C53.8 Overlapping lesion of cervix uteri
0.298 0.702 0.000
C53.1 Exocervix
0.298 0.702 0.000
D07.4 Penis
0.298 0.702 0.000
D00.1 Oesophagus
0.297 0.702 0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs
0.297 0.703 0.000
D01.9 Digestive organ, unspecified
0.295 0.704 0.000
D01.7 Other specified digestive organs
0.295 0.704 0.000
D01.5 Liver, gallbladder and bile ducts
0.295 0.704 0.000
D01.4 Other and unspecified parts of intestine
0.295 0.704 0.000
D01.1 Rectosigmoid junction
0.295 0.704 0.000
C84.0 Mycosis fungoides
0.291 0.709 0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.290 0.710 0.000
C68.8 Overlapping lesion of urinary organs
0.290 0.710 0.000
C68.1 Paraurethral glands
0.290 0.710 0.000
C57.8 Overlapping lesion of female genital organs
0.290 0.710 0.000
C57.7 Other specified female genital organs
0.290 0.710 0.000
C57.4 Uterine adnexa, unspecified
0.290 0.710 0.000
C57.3 Parametrium
0.290 0.710 0.000
C57.2 Round ligament
0.290 0.710 0.000
C57.1 Broad ligament
0.290 0.710 0.000
D06.0 Endocervix
0.289 0.710 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.289 0.711 0.000
C85.0 Lymphosarcoma
0.289 0.711 0.000
C91.0 Acute lymphoblastic leukaemia
0.288 0.712 0.000
C68.9 Urinary organ, unspecified
0.287 0.713 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.285 0.715 0.000
C97 Malignant neoplasms of independent (primary) multiple sites
0.283 0.716 0.000
C57.9 Female genital organ, unspecified
0.282 0.718 0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
0.281 0.719 0.000
C81.1 Nodular sclerosis
0.280 0.720 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.280 0.720 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.280 0.720 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.280 0.720 0.000
C84.3 Lymphoepithelioid lymphoma
0.280 0.720 0.000
C84.2 T-zone lymphoma
0.280 0.720 0.000
C84.1 Sezary's diease
0.280 0.720 0.000
D01.0 Colon
0.279 0.720 0.000
C81.7 Other Hodgkin's disease
0.277 0.723 0.000
D07.6 Other and unspecified male genital organs
0.277 0.723 0.000
D07.3 Other and unspecified female genital organs
0.277 0.723 0.000
D07.0 Endometrium
0.277 0.723 0.000
D00.2 Stomach
0.276 0.724 0.000
D06.9 Cervix, unspecified
0.276 0.724 0.000
C82.2 Large cell, follicular
0.275 0.725 0.000
C84.4 Peripheral T-cell lymphoma
0.274 0.726 0.000
C62.0 Undescended testis
0.273 0.727 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.270 0.730 0.000
C81.3 Lymphocytic depletion
0.270 0.730 0.000
Z51 Other medical care
0.266 0.734 0.000
Y43.0 Antiallergic and antiemetic drugs
0.265 0.735 0.000
C67.6 Ureteric orifice
0.264 0.736 0.000
C69 Malignant neoplasm of eye and adnexa
0.263 0.737 0.000
C81.0 Lymphocytic predominance
0.262 0.738 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.259 0.741 0.000
D07.2 Vagina
0.257 0.743 0.000
Y43.1 Antineoplastic antimetabolites
0.256 0.744 0.000
C38.4 Pleura
0.255 0.744 0.000
C60 Malignant neoplasm of penis
0.252 0.748 0.000
Y40 Systemic antibiotics
0.252 0.748 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.251 0.749 0.000
C57.0 Fallopian tube
0.250 0.749 0.000
Z51.9 Medical care, unspecified
0.249 0.751 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.247 0.752 0.000
C46 Kaposi's sarcoma
0.247 0.752 0.000
C70 Malignant neoplasm of meninges
0.247 0.753 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.246 0.753 0.000
C53.0 Endocervix
0.245 0.755 0.000
C48.2 Peritoneum, unspecified
0.245 0.755 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.239 0.761 0.000
Y43.9 Primarily systemic agent, unspecified
0.239 0.761 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.239 0.761 0.000
Y43.6 Enzymes, not elsewhere classified
0.239 0.761 0.000
Y43.5 Acidifying and alkalising agents
0.239 0.761 0.000
Y43.2 Antineoplastic natural products
0.239 0.761 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.236 0.764 0.000
C91.7 Other lymphoid leukaemia
0.236 0.764 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.236 0.764 0.000
C91.3 Prolymphocytic leukaemia
0.236 0.764 0.000
C91.2 Subacute lymphocytic leukaemia
0.236 0.764 0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.235 0.764 0.000
C67.9 Bladder, unspecified
0.234 0.766 0.000
C91.5 Adult T-cell leukaemia
0.233 0.767 0.000
C81.2 Mixed cellularity
0.232 0.767 0.000
C41.4 Pelvic bones, sacrum and coccyx
0.232 0.768 0.000
C67.5 Bladder neck
0.231 0.768 0.000
Y43.4 Immunosuppressive agents
0.231 0.769 0.000
Y40.9 Systemic antibiotic, unspecified
0.230 0.770 0.000
C81.9 Hodgkin's disease, unspecified
0.227 0.773 0.000
Z51.5 Palliative care
0.226 0.774 0.000
C74 Malignant neoplasm of adrenal gland
0.226 0.774 0.000
C69.9 Eye, unspecified
0.225 0.775 0.000
C42.4 hematopoietic and reticuloendothelial systems: Hematopoietic system, NOS (ICD-O-3 specific)
0.223 0.777 0.000
C42.3 hematopoietic and reticuloendothelial systems: Reticuloendothelial system, NOS (ICD-O-3 specific)
0.223 0.777 0.000
C42.2 hematopoietic and reticuloendothelial systems: spleen (ICD-O-3 specific)
0.223 0.777 0.000
C42.1 hematopoietic and reticuloendothelial systems: bone marrow (ICD-O-3 specific)
0.223 0.777 0.000
C42.0 hematopoietic and reticuloendothelial systems: blood (ICD-O-3 specific)
0.223 0.777 0.000
Y40.3 Macrolides
0.223 0.777 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.222 0.778 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.222 0.778 0.000
C54.8 Overlapping lesion of corpus uteri
0.219 0.781 0.000
C54.3 Fundus uteri
0.219 0.781 0.000
C54.2 Myometrium
0.219 0.781 0.000
C54.0 Isthmus uteri
0.219 0.781 0.000
C48.1 Specified parts of peritoneum
0.217 0.783 0.000
D00.0 Lip, oral cavity and pharynx
0.215 0.784 0.000
C63.9 Male genital organ, unspecified
0.215 0.785 0.000
C63.8 Overlapping lesion of male genital organs
0.215 0.785 0.000
C63.7 Other specified male genital organs
0.215 0.785 0.000
C63.2 Scrotum
0.215 0.785 0.000
C63.1 Spermatic cord
0.215 0.785 0.000
C63.0 Epididymis
0.215 0.785 0.000
C75 Malignant neoplasm of other endocrine glands and related structures
0.214 0.786 0.000
C40.9 Bone and articular cartilage of limb, unspecified
0.213 0.787 0.000
C40.8 Overlapping lesion of bone and articular cartilage of limbs
0.213 0.787 0.000
C40.3 Short bones of lower limb
0.213 0.787 0.000
C40.1 Short bones of upper limb
0.213 0.787 0.000
C40.0 Scapula and long bones of upper limb
0.213 0.787 0.000
C54.9 Corpus uteri, unspecified
0.212 0.788 0.000
C48.0 Retroperitoneum
0.211 0.789 0.000
C91.4 Hairy-cell leukaemia
0.209 0.791 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.209 0.791 0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum
0.208 0.792 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.208 0.792 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.207 0.793 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.205 0.795 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.205 0.795 0.000
Y40.8 Other systemic antibiotics
0.203 0.797 0.000
C84.5 Other and unspecified T-cell lymphomas
0.202 0.798 0.000
C41.8 Overlapping lesion of bone and articular cartilage
0.202 0.798 0.000
C41.3 Ribs, sternum and clavicle
0.202 0.798 0.000
C41.2 Vertebral column
0.202 0.798 0.000
Z51.8 Other specified medical care
0.200 0.800 0.000
C40.2 Long bones of lower limb
0.199 0.800 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.197 0.803 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.197 0.803 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.194 0.806 0.000
C50 Malignant neoplasm of breast
0.192 0.808 0.000
C69.0 Conjunctiva
0.192 0.808 0.000
Y40.5 Aminoglycosides
0.191 0.809 0.000
Y40.7 Antifungal antibiotics, systemically used
0.191 0.809 0.000
C41.0 Bones of skull and face
0.190 0.809 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.190 0.810 0.000
Z51.0 Radiotherapy session
0.189 0.811 0.000
Z51.3 Blood transfusion without reported diagnosis
0.189 0.811 0.000
C69.8 Overlapping lesion of eye and adnexa
0.188 0.811 0.000
C69.6 Orbit
0.188 0.811 0.000
C69.5 Lachrymal gland and duct
0.188 0.811 0.000
C69.4 Ciliary body
0.188 0.811 0.000
C69.2 Retina
0.188 0.811 0.000
C69.1 Cornea
0.188 0.811 0.000
Y58 Bacterial vaccines
0.187 0.813 0.000
Y59 Other and unspecified vaccines and biological substances
0.187 0.813 0.000
Y54.5 Other diuretics
0.186 0.814 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.186 0.814 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.184 0.815 0.000
Z51.6 Desensitisation to allergens
0.183 0.817 0.000
C41.9 Bone and articular cartilage, unspecified
0.182 0.817 0.000
Y54.7 Agents affecting calcification
0.182 0.818 0.000
Y40.6 Rifamycins
0.182 0.818 0.000
C60.8 Overlapping lesion of penis
0.181 0.819 0.000
C60.2 Body of penis
0.181 0.819 0.000
C60.1 Glans penis
0.181 0.819 0.000
C60.0 Prepuce
0.181 0.819 0.000
Y40.4 Tetracyclines
0.181 0.819 0.000
Y40.2 Chloramphenicol group
0.181 0.819 0.000
Y45.1 Salicylates
0.179 0.821 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.179 0.821 0.000
C13 Malignant neoplasm of hypopharynx
0.179 0.821 0.000
C91.9 Lymphoid leukaemia, unspecified
0.178 0.822 0.000
C46.9 Kaposi's sarcoma, unspecified
0.177 0.822 0.000
C46.8 Kaposi's sarcoma of multiple organs
0.177 0.822 0.000
C46.7 Kaposi's sarcoma of other sites
0.177 0.822 0.000
C46.3 Kaposi's sarcoma of lymph nodes
0.177 0.822 0.000
C46.2 Kaposi's sarcoma of palate
0.177 0.822 0.000
C46.1 Kaposi's sarcoma of soft tissue
0.177 0.822 0.000
C46.0 Kaposi's sarcoma of skin
0.177 0.822 0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified
0.177 0.822 0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system
0.177 0.822 0.000
C47.6 Peripheral nerves of trunk, unspecified
0.177 0.822 0.000
C47.5 Peripheral nerves of pelvis
0.177 0.822 0.000
C47.4 Peripheral nerves of abdomen
0.177 0.822 0.000
C47.3 Peripheral nerves of thorax
0.177 0.822 0.000
C47.2 Peripheral nerves of lower limb, including hip
0.177 0.822 0.000
C47.1 Peripheral nerves of upper limb, including shoulder
0.177 0.822 0.000
C47.0 Peripheral nerves of head, face and neck
0.177 0.822 0.000
C70.9 Meninges, unspecified
0.177 0.823 0.000
C70.1 Spinal meninges
0.177 0.823 0.000
C71 Malignant neoplasm of brain
0.176 0.824 0.000
Y44 Agents primarily affecting blood constituents
0.175 0.824 0.000
Y54.8 Agents affecting uric acid metabolism
0.173 0.827 0.000
Y45.5 4-Aminophenol derivatives
0.172 0.827 0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.172 0.828 0.000
C50.0 Nipple and areola
0.171 0.829 0.000
C83.7 Burkitt's tumour
0.170 0.830 0.000
Y54.3 Benzothiadiazine derivatives
0.169 0.831 0.000
C72.9 Central nervous system, unspecified
0.169 0.831 0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system
0.169 0.831 0.000
C72.5 Other and unspecified cranial nerves
0.169 0.831 0.000
C72.4 Acoustic nerve
0.169 0.831 0.000
C72.3 Optic nerve
0.169 0.831 0.000
C72.2 Olfactory nerve
0.169 0.831 0.000
C72.1 Cauda equina
0.169 0.831 0.000
Y52 Agents primarily affecting the cardiovascular system
0.169 0.831 0.000
C74.0 Cortex of adrenal gland
0.168 0.832 0.000
C70.0 Cerebral meninges
0.167 0.832 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.166 0.834 0.000
C74.1 Medulla of adrenal gland
0.164 0.835 0.000
Y49.2 Other and unspecified antidepressants
0.164 0.836 0.000
Y45.8 Other analgesics and antipyretics
0.164 0.836 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.161 0.839 0.000
C77.5 Intrapelvic lymph nodes
0.161 0.839 0.000
Y54.9 Mineral salts, not elsewhere classified
0.160 0.840 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.160 0.840 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.160 0.840 0.000
Y54.0 Mineralocorticoids
0.160 0.840 0.000
C83.6 Undifferentiated (diffuse)
0.159 0.841 0.000
C83.5 Lymphoblastic (diffuse)
0.159 0.841 0.000
C83.4 Immunoblastic (diffuse)
0.159 0.841 0.000
C83.2 Mixed small and large cell (diffuse)
0.159 0.841 0.000
D07.1 Vulva
0.158 0.841 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.159 0.841 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.158 0.842 0.000
C41.1 Mandible
0.157 0.842 0.000
C50.1 Central portion of breast
0.158 0.842 0.000
Y55.4 Expectorants
0.157 0.843 0.000
C74.9 Adrenal gland, unspecified
0.156 0.844 0.000
Y53.4 Other laxatives
0.155 0.845 0.000
C13.9 Hypopharynx, unspecified
0.154 0.846 0.000
C00 Malignant neoplasm of lip
0.154 0.846 0.000
C75.8 Pluriglandular involvement, unspecified
0.153 0.846 0.000
C75.5 Aortic body and other paraganglia
0.153 0.846 0.000
C75.4 Carotid body
0.153 0.846 0.000
C75.3 Pineal gland
0.153 0.846 0.000
C75.2 Craniopharyngeal duct
0.153 0.846 0.000
C75.0 Parathyroid gland
0.153 0.846 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.152 0.848 0.000
C07 Malignant neoplasm of parotid gland
0.152 0.848 0.000
C05 Malignant neoplasm of palate
0.150 0.850 0.000
Y45.4 Antirheumatics
0.150 0.850 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.149 0.850 0.000
Y55.5 Anticommon cold drugs
0.149 0.850 0.000
Y55.3 Antitussives
0.149 0.850 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.149 0.850 0.000
Y55.0 Oxytocic drugs
0.149 0.850 0.000
Y54.4 Loop [high-ceiling] diuretics
0.149 0.851 0.000
C50.3 Lower-inner quadrant of breast
0.149 0.851 0.000
C75.1 Pituitary gland
0.149 0.851 0.000
C72.0 Spinal cord
0.148 0.851 0.000
C45 Mesothelioma
0.148 0.851 0.000
Y48 Anaesthetics and therapeutic gases
0.148 0.852 0.000
C75.9 Endocrine gland, unspecified
0.148 0.852 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.148 0.852 0.000
Y49.9 Psychotropic drug, unspecified
0.147 0.853 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.147 0.853 0.000
Y49.7 Psychostimulants with abuse potential
0.147 0.853 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.147 0.853 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.147 0.853 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.147 0.853 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.147 0.853 0.000
C71.4 Occipital lobe
0.147 0.853 0.000
C14.0 Pharynx, unspecified
0.147 0.853 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.146 0.853 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.146 0.854 0.000
Y46.7 Anti-Parkinsonism drugs
0.145 0.855 0.000
Y45.2 Propionic acid derivatives
0.145 0.855 0.000
C50.5 Lower-outer quadrant of breast
0.144 0.856 0.000
Y46.4 Iminostilbenes
0.143 0.857 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.